CORBUS PHARMACEUTICALS HOLDI (CRBP)

US21833P3010 - Common Stock

34.25  +0.75 (+2.24%)

After market: 34.25 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.00880.00K3.94M36.14M
Operating Expenses
45.08M34.84M56.87M126.75M113.25M
Research and Development
31.17M16.14M36.45M98.27M89.60M
Selling, General, and Administrative Expenses
13.91M18.70M20.43M28.48M23.64M
Operating Income
-45.08M-34.84M-55.99M-122.81M-77.10M
Interest Income/Expense
-2.92M-2.46M-1.55M-1.73M1.07M
Other Income/Expense
3.39M-50.00K11.90M13.27M4.58M
Non Recurring Items
0.00-5.00MN/AN/AN/A
Income Before Taxes
-44.60M-42.35M-45.64M-111.27M-71.45M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-44.60M-42.35M-45.64M-111.27M-71.45M
EBITDA
-44.44M-34.08M-54.99M-121.69M-76.36M
 
Per Share Data
EPS Diluted Total Ops
-10.31-10.15-11.13-42.79-33.55
Non GAAP EPS
-10.15-10.41-7.64-1.47-1.13
 
Statistics
Profit Margin
N/AN/A-5186.36%-2824.11%-197.70%
Operating Profit Margin
N/AN/A-6362.50%-3117.01%-213.34%

All data in USD

Charts